(Q37794342)

23 August 2017

title

Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance (English)

1 reference

23 August 2017

0 references

antibiotic resistance

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20880409

22 July 2024

author name string

A. Oliver

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20880409

22 July 2024

A. Mena

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20880409

22 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20880409

22 July 2024

publication date

1 July 2010

1 reference

full work available at URL

23 August 2017

http://www.clinicalmicrobiologyandinfection.com/article/S1198743X1461733X/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20880409

https://api.elsevier.com/content/article/PII:S1198743X1461733X?httpAccept=text/xml

22 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

https://api.elsevier.com/content/article/PII:S1198743X1461733X?httpAccept=text/plain

22 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Clinical Microbiology and Infection

22 July 2024

published in

1 reference

23 August 2017

volume

16

1 reference

23 August 2017

issue

7

1 reference

23 August 2017

page(s)

798-808

1 reference

Selection for high mutation rates in chemostats

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Evolution of high mutation rates in experimental populations of E. coli

22 July 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Role of mutator alleles in adaptive evolution.

22 July 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Proliferation of mutators in A cell population

22 July 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut

22 July 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Experimental adaptation of Salmonella typhimurium to mice

22 July 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa

22 July 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Coevolution with viruses drives the evolution of bacterial mutation rates.

22 July 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

High mutation frequencies among Escherichia coli and Salmonella pathogens

22 July 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

22 July 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

The microbiology of mutability

22 July 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation

22 July 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair

22 July 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Escherichia coli mutator genes

22 July 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

22 July 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Mismatch repair in replication fidelity, genetic recombination, and cancer biology

22 July 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Interspecies gene exchange in bacteria: the role of SOS and mismatch repair systems in evolution of species.

22 July 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Amplification of mutator cells in a population as a result of horizontal transfer

22 July 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

The Pseudomonas aeruginosa pfpI gene plays an antimutator role and provides general stress protection

22 July 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Mutator genes giving rise to decreased antibiotic susceptibility in Pseudomonas aeruginosa

22 July 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Specialized DNA polymerases, cellular survival, and the genesis of mutations

22 July 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Stress-induced mutagenesis in bacteria.

22 July 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Mutation and evolution of antibiotic resistance: antibiotics as promoters of antibiotic resistance?

22 July 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa.

22 July 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Fitness of an Escherichia coli Mutator Gene

22 July 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Hypermutability Impedes Cooperation in Pathogenic Bacteria

22 July 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

The effect of elevated mutation rates on the evolution of cooperation and virulence of Pseudomonas aeruginosa

22 July 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli

22 July 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

High Rate of Macrolide Resistance inStaphylococcus aureusStrains from Patients with Cystic Fibrosis Reveals High Proportions of Hypermutable Strains

22 July 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains

22 July 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum

22 July 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections

22 July 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease

22 July 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients

22 July 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis.

22 July 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

High frequency of mutator strains among human uropathogenic Escherichia coli isolates.

22 July 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori

22 July 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Mismatch repair and the regulation of phase variation in Neisseria meningitidis

22 July 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation.

22 July 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family

22 July 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Factors associated with antimicrobial resistance among clinical isolates of Klebsiella pneumoniae: 1-year survey in a French university hospital

22 July 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Inactivation of mismatch repair increases the diversity of Vibrio parahaemolyticus

22 July 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations.

22 July 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Mutator clones of Neisseria meningitidis in epidemic serogroup A disease

22 July 2024

44

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate

22 July 2024

45

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

22 July 2024

46

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Lung infections associated with cystic fibrosis

22 July 2024

47

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation

22 July 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis

22 July 2024

49

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis

22 July 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants

22 July 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Characterization of the GO system of Pseudomonas aeruginosa

22 July 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.

22 July 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates

22 July 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients.

22 July 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis

22 July 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation

22 July 2024

57

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections.

22 July 2024

58

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa

22 July 2024

59

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis

22 July 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance

22 July 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

The role of mutators in the emergence of antibiotic-resistant bacteria

22 July 2024

62

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

22 July 2024

63

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test

22 July 2024

64

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy

22 July 2024

65

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections

22 July 2024

66

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

The GO system prevents ROS-induced mutagenesis and killing in Pseudomonas aeruginosa

22 July 2024

67

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes

22 July 2024

68

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients

22 July 2024

69

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Epidemiology Of Chronic Pseudomonas aeruginosa Infections In Cystic Fibrosis

22 July 2024

71

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Adaptive radiation in a heterogeneous environment

22 July 2024

72

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.

22 July 2024

73

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa

22 July 2024

74

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice.

22 July 2024

75

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain.

22 July 2024

76

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa.

22 July 2024

77

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Self-generated diversity produces "insurance effects" in biofilm communities

22 July 2024

78

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Endogenous oxidative stress produces diversity and adaptability in biofilm communities

22 July 2024

79

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Role of mutation in Pseudomonas aeruginosa biofilm development.

22 July 2024

80

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.

22 July 2024

81

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli.

22 July 2024

83

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants

22 July 2024

84

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion

22 July 2024

85

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.

22 July 2024

86

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro

22 July 2024

87

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants

22 July 2024

88

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Dynamics of Pseudomonas aeruginosa genome evolution

22 July 2024

90

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Pseudomonas aeruginosaMicroevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence

22 July 2024

91

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa.

22 July 2024

92

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

Increased mutability of Pseudomonas aeruginosa in biofilms

22 July 2024

93

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03250.X

22 July 2024

Identifiers

1 reference

23 August 2017

1 reference